Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Expression Analysis Announces 2013 Grant Program

Published: Monday, April 08, 2013
Last Updated: Monday, April 08, 2013
Bookmark and Share
Two recipients to receive cutting-edge services from Expression Analysis and Illumina to advance new applications in genomics research.

Expression Analysis (EA), a Quintiles company today announced a grant program that provides scientists with leading-edge products and services to advance genomics research. In the fifth year of EA’s grant program, EA and Illumina will award two grant winners fully-funded exome and RNA sequencing services along with array-based methylation analysis as part of the companies’ integrated biology grant.

“This grant program illustrates our commitment to advancing new applications in genomics research,” said Steve McPhail, President of EA. “We are encouraging researchers to explore the power of an integrated biological approach in their genetic research studies.”

“We are very excited to enable this comprehensive approach using the latest advances in genomic studies enhanced with gene expression and regulation,” said Tristan Orpin, Senior Vice President and Chief Commercial Officer of Illumina. “We look forward to another successful partnership with EA in co-sponsoring these grants.”

Integrated biology is a scientific approach that has considerable advantages over other approaches within biology and biomedical research—including interpreting interactions in genetic research studies through a comprehensive, systems view rather than a single scientific lens that can exclude significant biological factors.

The integrated biology grant includes:

•    Whole Genome DNA Methylation, which plays a critical role in the regulation of gene expression and is known to be an essential mechanism for guiding normal cellular development and maintaining tissue identities;
•    RNA Sequencing, which enables a more comprehensive and quantitative view of the entire transcriptome, providing accurate analysis of gene expression. This also enables identification of novel transcripts, novel isoforms, alternative splice sites, allele-specific expression, cSNPs, and rare transcripts all in a single experiment; and
•    Exome Sequencing, which integrates protein coding regions of the human genome through enrichment strategies that target all exons, UTRs and other functionally annotated regions of interest.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

EPA Awards $27 Million Contract to Expression Analaysis
Renewed contract for expansion of ToxCast's genomic data.
Thursday, August 09, 2012
Expression Analysis Announces RNA-SEQ Grant Program
EA teams with Golden Helix and Illumina to offer three fully-funded grants for RNA-Seq studies.
Tuesday, February 21, 2012
Expression Analysis Welcomes New Vice President of Operations
EA announces the addition of Tyler Aldredge to its executive management team. Tyler will assume the role of Vice President of Laboratory Operations.
Wednesday, September 21, 2011
Expression Analysis Hires Director of Business Development
Expression Analysis announces that Jeff Fitzgerald has joined their management team as Director of Business Development.
Friday, September 09, 2011
EA Announces Research Acceleration Grant Focusing on Kinase Mutations and Cancer
Company announces research grant to investigate and draw parallels between specific cancers and recurring mutations in specific kinases, using targeted genome sequencing.
Thursday, February 03, 2011
Expression Analysis® Receives CLIA Certification
The company enters its tenth year of providing genomic expertise; something the company refers to as “Genomic Know-How™”.
Wednesday, February 02, 2011
Expression Analysis and Illumina Fund GWAS and Data Analysis Grant Program to Support Cancer Research
Illumina to provide microarrays and reagents while Expression Analysis will perform services and data analysis consultation at no cost to the recipient of the selected study.
Wednesday, November 03, 2010
Expression Analysis® Expands Scientific Management Team
Expression Analysis, Inc. has announced two additions to its scientific management team Patrick Hurban, Ph.D. and Louise Grant.
Wednesday, April 28, 2010
Expression Analysis Launches a new Website and Offers Scientists
The redesigned website allows researchers and scientists to easily navigate and locate the information and services.
Thursday, August 06, 2009
Expression Analysis Adopts Cure Kids Cancer Coalition
Fund-raising will begin at Upcoming American Society of Human Genetics Meeting.
Monday, November 03, 2008
Expression Analysis Announces a GWAS Data Analysis and Resequencing Grant
Expression Analysis, the industry’s leading provider of genomic services for clinical trials and research, announces they will award a Genome Wide Association Study (GWAS) Data Analysis and Resequencing Grant.
Thursday, October 02, 2008
Expression Analysis Awarded EPA Contract for ToxCast™ Genomic Services
Expression Analysis will provide gene expression and genotyping services for EPA's ToxCast™ Program.
Friday, April 13, 2007
Expression Analysis Relocates to Larger Laboratory Facility While Expanding its Genomic Services and Staff
The Company moves to new facility to expand its high throuput testing by installing new tools from Illumina, Applied Biosystems and Luminex.
Monday, February 26, 2007
Expression Analysis Announces its Participation in the First Phase of the MAQC Project
This first phase of the MAQC Project was focused on reproducibility of results among seven microarray platforms and three other gene expression platforms.
Wednesday, September 13, 2006
Scientific News
Shedding Light on HIV Vaccine Design
Broadly speaking - Mathematical modelling of host-pathogen coevolution sheds light on HIV vaccine design.
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Automated Patch Clamping Trends
Learn more about current practices, preferences and metrics in ion channel drug screening using APC technology.
Lab-on-a-Stick: Miniaturised Clinical Testing For Fast Detection Of Antibiotic Resistance
A portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed by academics at Loughborough University and the University of Reading.
Genetic Ancestry of Cultivated Strawberry Unravelled
UNH scientists constructed a linkage map of the seven chromosomes of the diploid Fragaria iinumae, which allows them to fill in a piece of the genetic puzzle about the eight sets of chromosomes of the cultivated strawberry.
Progress In Vaccination Against Vespid Venom
Researchers at the Helmholtz Zentrum München and the Technical University Munich have presented a method which facilitates a personalised procedure for wasp allergy sufferers.
New Drug Target for Inflammatory Disorders
Penn study finds enigmatic molecules maintain equilibrium between fighting infection and inflammatory havoc.
Breast Cancer Cells Found To Switch Molecular Characteristics
Spontaneous interconversion between HER2-positive and HER2-negative states could contribute to progression, treatment resistance in breast cancer.
Mechanisms of Calcium Blockers
Researchers describe how the fundamental mode of action of two distinct chemical classes of calcium channel blockers differs.
Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy
Genetic test can help predict survival and guide treatment options.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!